Maltin Wealth Management, Inc. Johnson & Johnson Transaction History

Maltin Wealth Management, Inc.

$165 Million
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	SELL	$155.22 - $162.74 $4,501 - $4,719	-29 Reduced 2.2%	1,290 $204,000
Q4 2023 Jan 18, 2024	SELL	$145.6 - $158.88 $552,260 - $602,631	-3,793 Reduced 74.2%	1,319 $206,000
Q3 2023 Oct 10, 2023	SELL	$155.75 - $174.48 $778 - $872	-5 Reduced 0.1%	5,112 $796,000
Q2 2023 Aug 03, 2023	BUY	$154.35 - $166.11 $77,638 - $83,553	503 Added 10.9%	5,117 $846,000
Q2 2023 Jul 11, 2023	SELL	$154.35 - $166.11 $76,711 - $82,556	-497 Reduced 9.72%	4,614 $763,000
Q1 2023 Apr 19, 2023	BUY	$151.05 - $180.26 $19,636 - $23,433	130 Added 2.61%	5,111 $792,000
Q4 2022 Feb 16, 2023	SELL	$160.2 - $179.79 $304,540 - $341,780	-1,901 Reduced 27.62%	4,981 $879,000
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $161 - $179	-1 Reduced 0.01%	6,882 $1.12 Million
Q2 2022 Aug 05, 2022	BUY	$168.19 - $186.01 $3,700 - $4,092	22 Added 0.32%	6,883 $1.22 Million
Q1 2022 May 06, 2022	BUY	$158.14 - $179.59 $395,666 - $449,334	2,502 Added 57.4%	6,861 $1.22 Million
Q4 2021 Feb 02, 2022	BUY	$155.93 - $173.01 $97,768 - $108,477	627 Added 16.8%	4,359 $746,000
Q3 2021 Nov 09, 2021	BUY	$161.5 - $179.47 $6,298 - $6,999	39 Added 1.06%	3,732 $603,000
Q2 2021 Jul 23, 2021	SELL	$159.48 - $171.07 $109,084 - $117,011	-684 Reduced 15.63%	3,693 $608,000
Q1 2021 Apr 29, 2021	SELL	$153.07 - $170.48 $19,592 - $21,821	-128 Reduced 2.84%	4,377 $719,000
Q4 2020 Jan 20, 2021	BUY	$137.11 - $157.38 $617,680 - $708,996	4,505 New	4,505 $709,000
Q2 2020 Aug 05, 2020	SELL	$128.81 - $155.51 $481,491 - $581,296	-3,738 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$111.14 - $153.99 $415,441 - $575,614	3,738 New	3,738 $490,000

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Maltin Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Maltin Wealth Management, Inc. with notifications on news.

Account